Screener
Beta Bionics BBNX Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Beta Bionics in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The source filing: Beta Bionics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323777
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $44,318 | $31,576 |
| Restricted cash, current | 100 | 100 |
| Short-term investments | 136,171 | 187,549 |
| Accounts receivable, net | 18,053 | 17,118 |
| Inventories | 23,918 | 21,722 |
| Prepaid expenses and other current assets | 8,474 | 9,840 |
| Total current assets | 231,034 | 267,905 |
Item 1. Financial Statements.
FAQ
- What is Beta Bionics's short-term investments?
- Beta Bionics (BBNX) reported short-term investments of $136.17M in Q2 2026.
- How has Beta Bionics's short-term investments changed year-over-year?
- Beta Bionics's short-term investments decreased by 36.6% year-over-year, from $214.65M to $136.17M.
- What is the long-term trend for Beta Bionics's short-term investments?
- Over 2 years (2023 to 2025), Beta Bionics's short-term investments has grown at a 63.5% compound annual growth rate (CAGR), from $70.18M to $187.55M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Beta Bionics's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude